POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION: Affected lot is labelled with the incorrect strength and ingredient
Last updated
Summary
Product
POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION
Issue
Health products - Labelling
What to do
See instructions below.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Potassium Chloride in Lactated Ringer’s Injection USP | Potassium Chloride in Lactated Ringer’s Injection USP | DIN 02243421 | Solution | CALCIUM CHLORIDE 20 MG / 100 ML, POTASSIUM CHLORIDE 179 MG / 100 ML, SODIUM CHLORIDE 600 MG / 100 ML, SODIUM LACTATE 310 MG / 100 ML | W2I07A1 |
Issue
Affected lot is labelled with the incorrect strength and ingredient
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Healthcare Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Baxter Corporation
7125 Mississauga Road, Mississauga
ON, L5N 0C2
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-72083
Get notified
Receive notifications for new and updated recalls and alerts by category.